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Abstract
Throughout the world, animal models are being used as simulators of human anatomy 
and pathophysiology with most of the investigations and treatments first tested on them. 
Double incontinence (DI) includes both urinary and anal incontinence. This chapter is 
focused on the use of animals as models to understand pathogenesis, diagnosis and man‐
agement of double incontinence (DI). DI is a complex disease with variant prevalence 
around the world which has a severe impact on quality of life (Qol). Many studies are 
designed to employ rodent and rabbit models to understand the pathogenesis of urinary 
and fecal incontinence. Urodynamic studies including leak point pressure (LPP) and ure‐
thral pressure profilometry (UPP) are used in establishing diagnosis of stress urinary 
incontinence. Rats have also been used to study fecal incontinence using neurophysi‐
ological and sacral nerve stimulation tests. The surgical treatment of double incontinence 
involves use of mesh, which was initially tested on animals. Animal models have also 
been used to train surgeons for perineal tear repair surgery. We conclude that the use of 
animal models provides best approach to learn these specialized surgical skills for medi‐
cal practitioners and researchers.
Keywords: animal model, double incontinence, stress incontinence, fecal incontinence, 
human
1. Introduction
The prevalence of female urinary incontinence (UI) in Europe ranges from 14.1 to 68.8% and 
increases with age [1]. Specifically, stress urinary incontinence (SUI) is highest among all 
types of UI and is estimated at 23.7% [2]. The prevalence of fecal incontinence (FI) ranges 
from 2.2 to 50% in women with urinary incontinence or pelvic organ prolapse [3]. FI and UI 
are pelvic floor disorders (PFD) which lead to social embarrassment and have poor impact 
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on quality of life. Over $12 billion are spent annually for management of SUI in women [4]. 
The average annual total cost for fecal incontinence is estimated at $4110 per person [5]. Stress 
urinary incontinence (SUI) may be defined as involuntary loss of urine on effort or physical 
exertion (e.g., sporting activities), or on sneezing or coughing. Urgency urinary incontinence 
(UUI) relates to involuntary loss of urine associated with a desire to void, while anorectal 
incontinence (AI) is a complaint of involuntary loss of feces or flatus.
The ultimate success of long‐term management for double incontinence (DI) is based on an 
understanding of disease pathophysiology. Little is known about the degree to which UI and 
FI share risk factors. Animal models have been used to understand pathogenesis of these 
conditions in humans and for developing novel treatment alternatives. Even though many 
animal models have been developed to understand pathogenesis, yet many of etiological fac‐
tors are not explained. Many animal models are used as simulators for teaching surgical skills 
but long‐term studies have not shown the desired improvement in surgical outcome [6]. The 
surgical procedures in humans were developed through the use and application of animal 
model as slings and trocar‐driven implants [7] for anti‐incontinence procedures.
Urinary incontinence is relatively easy to understand when compared to fecal incontinence 
as anal sphincter defects and FI are complicated surgical problems. Research on use of stem 
cell for treatment of FI was conducted on rabbits by an iatrogenic sphincter defect, created by 
cutting of anal sphincter. Human umbilical cord matrix (hUCM) and stem cells from rabbit 
femur and tibia were harvested and transplanted into injured sphincters which later showed 
an improvement in their function. Bone marrow‐derived stem cells and mesenchymal cells 
of animals have shown to enhance contractile function of anal sphincter without surgical 
repair [8]. The limitation of using animals is in their difference with anatomy and size of vis‐
cera, which affects the functional outcome. Human cadavers have been used for a long time 
for teaching anatomy, but due to ethical issues animals were introduced in medical teach‐
ing. Animal models were found quite effective, but because of major difference in functional 
anatomy, mannequins were introduced for medical teaching and learning. There are many 
centers for simulation‐based innovation for medical education (SIME), which probably would 
give similar results [9].
Most of the studies on new medical and surgical treatment involve the use of animal mod‐
els for preclinical trials. In this chapter, we discussed use of animal models for relevant 
research, procedures on pathogenesis and surgical training techniques for DI. We have 
used standardized terminology for definitions as described by the International Continence 
Society (ICS) and International Urogynecological Association (IUGA) joint report on ter‐
minology [10, 11].
2. Methods of determining SUI in animal models
SUI is a clinical diagnosis mainly by history and physical examination. ICS has defined uro‐
dynamic stress incontinence as involuntary leakage of urine during filling cystometry, asso‐
ciated with increased intra‐abdominal pressure, in the absence of a detrusor contraction 
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[10]. The role of urodynamic studies (UDS) is important in identifying types of SUI. Types 
of SUI can be determined with valsalva leak point pressure (VLPP) and urethral pressure 
profilometry (UPP). According to Blaivis, SUI types 1 and 2 are related to urethral hyper 
mobility with VLPP > 90 cm of water for type 1 and between 60 and 90 cm of water for type 2, 
respectively. Blaivis type 3 SUI is with VLPP < 60 cm water, also known as intrinsic sphincter 
deficiency (ISD). In addition, a urethral pressure profile (UPP which is urethral pressure–
detrusor pressure) < 20 cm water is also seen in the cases of ISD [12]. Animal models that 
simulate SUI provide an assessment of the mechanism of risk factors, including childbirth 
injuries, preclinical testing of new treatments and therapies for SUI. Since animals cannot 
express intent, the use of these animal models has been focused on measuring decreased 
urethral resistance [13].
2.1. Sneeze testing
SUI is clinically assessed on humans as observation of involuntary leakage from the urethra 
with effort or physical exertion, or on sneezing or coughing [10]. Based on the urinary leak 
with a rise in abdominal pressure, sneeze test can be performed in female rat under anesthe‐
sia. A whisker cut from anesthetized rat was used to tickle its nose. Even under anesthesia the 
rat responded with a small sneeze, which transiently increased abdominal pressure. Karl et al. 
performed cystometry with methylene blue dye in bladder to detect urinary leak. The animal 
was diagnosed as incontinent if they leaked during the sneeze test and continent if no leak on 
sneezing was observed [13, 14].
2.2. LPP testing
The human bladder functions by storage and voiding of urine. Voiding is accompanied by 
an increase in detrusor pressure and a decrease in urethral pressure. In leak point pressure 
(LPP) testing [15], rats were anesthetized and a transperitoneal catheter implanted in the blad‐
der dome was tunneled subcutaneously from the back of the bladder neck to an exit via the 
skin. The catheter was capped and the skin incision closed in two layers. The bladder catheter 
was connected to both a syringe pump and a pressure transducer. The bladder when filled 
with room‐temperature saline through the catheter, the bladder pressure was recorded via a 
microtip transducer urethral catheter. Pressure and force transducer signals were amplified 
and recorded on a chart recorder. All bladder pressures were referenced to air pressure at 
the level of the bladder very similar to LPP assessment in humans with use of external trans‐
ducers. The three commonly used mechanisms are manual pressure/Crede’s LPP, electrical 
stimulation LPP and table tilt LPP [16–18].
2.2.1. Manual LPP testing
To perform manual LPP testing in rats, they put supine on table and a passive/manual 
abdominal pressure is applied and increased gradually, thus increasing the vesical pressure 
until leakage is observed at the urethral meatus. The peak bladder pressure was taken as 
the LPP. After leak, the external pressure is rapidly removed and bladder pressure quickly 
returns to baseline [17].
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2.2.2. Vertical tilt table LPP
Rat is mounted on a vertical tilt table to keep the bladder erect during UDS, similar to human 
studies. A saline reservoir is connected to a suprapubic catheter to passively increase bladder 
pressure by elevating it and maintaining it at a range of pressures (20, 40 and 60 cm H2O) [19]. In this method, the spinal cord is often transected usually at T8–T9. This transaction elimi‐
nates the supraspinal reflex voiding but preserves the urethral reflexes induced by bladder 
distention, which are predominantly organized in the lumbosacral spinal cord [20]. Studies 
have shown comparable results of LPP with sneeze test, manual pressure test and vertical tilt 
table test [21].
2.2.3. Electrical stimulation LPP testing
Electrical stimulation of abdominal muscles for 1 s induces sudden increase in both the intra‐
abdominal and the intravesical pressure. The lowest intravesical pressure that induced fluid 
leakage from the urethral orifice (leak point pressure) and the maximal intravesical pressure 
without urine leakage were recorded and were used to evaluate urethral resistance. However, 
like tilt table testing, electrical stimulation LPP testing also requires spinal cord transection, 
suppressing supraspinal continence control [22].
2.3. Urethral closure pressure testing
Effects of stem cell transplantation in rats were evaluated through urodynamic testing, and 
morphologic changes of the urethra and surrounding tissues were studied [23] both before 
and after transplantation. The bladder catheter was used as an intraurethral pressure mea‐
surement catheter, connecting it to a three‐limb tube through a conversion joint. One end of 
that three‐limb tube was connected to the intraurethral pressure sensor, and the other end 
was connected to the micropump, maintaining the original intraurethral pressure measure‐
ment catheter. Pressure was set at 0, and infusion by micropump at rate of 0.25 ml/min was 
started. Urethral pressure profilometry (UPP) rod was used to pull the intraurethral pres‐
sure measurement catheter at 0.1 mm/s traction speed. Meanwhile, intraurethral pressure 
and intrabladder pressure were recorded. Maximum urethral closure pressure (MUCP) was 
intraurethral pressure minus intrabladder pressure. Functional urethra length (FUL) was also 
calculated. Transplantation of adipose‐derived stem cells significantly strengthened local ure‐
thral muscle layers and significantly improved the morphology and function of sphincters.
3. Establishing the causes of incontinence in animals
3.1. Causes of SUI
The childbirth injury leads to SUI due to musculofascial and neurovascular damage causing 
weakness in pelvic floor support [24]. Rodents are used to establish the vaginal injury as a lead‐
ing cause of SUI which occur secondary to vaginal dilatation (VD) during childbirth in human. 
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Several studies [25, 26] have demonstrated vaginal injury by VD which is induced by using a 
Foley catheter with cut tip and inflated with different fluid volumes from 2 to 4 ml. This creates 
pressure in vagina and iatrogenic injury to the urethra, bladder, vagina and levator muscles. 
Functionally, VD results in decreased urethral resistance, as evidenced by lowered leak point 
pressures on urodynamic testing done in most of the VD studies [27]. In a study by Lin et al., VD 
was created in mice by 0.1–0.3 ml balloon in comparison with sham distension. LPP was signifi‐
cantly lower in groups after VD with 0.2–0.3 ml as compared to sham [28]. Research has shown 
that this procedure has helped in understanding molecular factors like chemokines, neuro‐
regenerative agents and pharmacological agents that contribute to functional recovery includ‐
ing stem cell mobilization following injury [27, 29]. It has also helped in evaluation of the impact 
of contributing/decompensating factors in the pathophysiology and recovery of continence.
3.2. Causes of UUI
Urinary urge incontinence is observed among patient of overactive bladder (OAB) which is 
called wet OAB. There are many pathophysiological bases for its explanation including neuro‐
genic and myogenic theories. It has been established through animal studies that urge incon‐
tinence is predominantly due to a defect in bladder muscle [30]. In a study on pigs, unstable 
bladder contractions were produced against induced outflow obstruction, bladder distention 
and bladder transaction. In affected pigs, stimulation of the spinal roots could no longer alter 
detrusor contraction. Similarly, sectioning of the spinal roots in these animals did not elimi‐
nate the unstable pressure rise explaining myogenic basis of OAB [31]. These manipulations 
do not eliminate the possibility of increased neuronal firing at the ganglionic level. However, 
recently, it has been shown that both hexamethonium (which blocks ganglionic transmission) 
and tetrodotoxin (TTX, which abolishes all neuronal activity) inhibit micturition but do not 
abolish unstable contractions in the pigs or rats [32, 33], hence supporting myogenic theory. 
The majority of the structural changes seen were obtained with light microscopic techniques, 
and local detrusor changes were found similar to those among human with OAB.
3.3. Causes of DI
The innervation of the external urethral sphincter (EUS) from the pudendal nerve is similar 
between rats and humans [34]. In female rats, the motor pudendal nerve bifurcates within 
Alcock’s canal into separate fascicles that innervate the external anal sphincter (EAS) and EUS. 
The pudendal nerve controls EUS activity, including tonic activity during continence, and acti‐
vates to strengthen the guarding response to prevent urinary leakage [35]. It can be trapped 
and injured during vaginal childbirth because it passes through Alcock’s canal in the ischiorec‐
tal fossa, especially between the sacrospinous and the sacrotuberous ligaments [36]. Pudendal 
nerve crush (PNC) injury was induced in rats simulating childbirth injury, leading to deficiency 
of EUS and causing SUI [37]. Another rat study demonstrated the Pudendal nerve injury effects 
on external anal sphincter similar to injury during child birth in human affecting EAS and 
causing FI. In Healy et al.’s study [38], one group of rats used for the experiment had induced 
bilateral inferior rectal nerve crush (Group A) injury which then acted as a positive control and 
was observed for EAS effects. In another group (Group B), an intrapelvic retro‐uterine balloon 
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inflation was performed, mimicking the pressure effects of child birth on the pelvic side wall 
and pelvic floor. Both groups of rats showed signs of EAS muscle atrophy and denervation, 
leading to FI. However, EMG signs of re‐innervation were seen in both groups and recovery of 
muscle mass at 4 weeks, mimicking human pathophysiology of fecal incontinence.
4. Use of animal model in conservative treatment of incontinence
Since conservative management involves the use of medicine with many side effects, labora‐
tory animals are used in preclinical drug trials. Several animal models have been used to 
evaluate the best possible conservative remedies for treating both urinary and fecal incon‐
tinence. Animal models were to test midurethral slings for surgical treatment of SUI which 
currently provides the best surgical cure. An outline of conservative management of double 
incontinence is shown in Figure 1.
4.1. Conservative management of SUI
Conservative treatment of SUI includes lifestyle interventions, pelvic floor muscle training, 
electrical stimulation, vaginal cones, urethral plugs and the drug duloxetine. Medical treat‐
ment has been tried and tested on animal models to assess their safety and effects on nervous 
system in improving SUI.
Figure 1. Conservative management of double incontinence.
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4.1.1. Selective norepinephrine reuptake inhibitor
Venlafaxine is a selective norepinephrine (NE) reuptake inhibitor, and it significantly 
decreases the contraction of bladder muscle and increases urethral resistance. This was ini‐
tially tested on rabbits and rodents. Bladder and proximal urethral muscle strips were electri‐
cally stimulated, and their contractile responses were measured both pre‐ and posttreatment 
with venlafaxine. It was observed that it significantly increased the contraction of urethral 
strips (P = 0.008) tested by urethral pressure profilometry (UPP) [39].
4.1.2. Norepinephrine (NE) and serotonin (5‐HT) reuptake inhibitor
Duloxetine, a norepinephrine (NE) and serotonin (5‐HT) reuptake inhibitor, can prevent 
SUI by facilitating noradrenergic and serotonergic systems in the spinal cord at S3 level 
(nucleus of Onuf) to enhance the sneeze‐induced active urethral closure mechanism. Based 
on this mechanism, duloxetine is currently being used in humans for conservative manage‐
ment of SUI. Before the human trials, it was tested on cat sphincter [40] and in rat models. 
Duloxetine caused urethral closing contractions and increased the urethral resistance (leak 
point pressure) measured using a microtip transducer catheter in the middle urethra of rat 
models [41].
4.1.3. Stem cell therapy
One of the SUI causes includes urethral sphincter deficiency which is called type III SUI or 
intrinsic sphincter deficiency (ISD). This occurs usually due to inherent defects in the collagen 
and elastin of urethral sphincter. Many preclinical trials have investigated whether trans‐
plantation of patient’s own skeletal muscle‐derived cells (SkMDCs) can restore the sphincter 
musculature. The specific cell type of SkMDCs is myoblasts, satellite cells, muscle progenitor 
cells, or muscle‐derived stem cells. The other stem cell (SC) types used for urethral defects 
include those from the bone marrow, umbilical cord blood and adipose tissue. These cells are 
injected as periurethral injections. Herrera‐Imbroda et al. used rat models for SC injection, 
and rats were assessed by LPP testing for therapeutic efficacy of SC treatment [42]. The study 
also used histological assessment, which revealed the sphincter muscle content, existence of 
transplanted SCs and possible differentiation of these SCs.
Rodents were also used to explore the feasibility, safety and efficacy of cellular regi‐
men to treat SUI. SUI was induced by vaginal dilatation (VD), and cystoscopic urethral 
injections of bone marrow or adipose tissue‐derived mesenchymal stromal cells (BMSC/
ADSC) were given to rats. It was observed that MSCs restored the continence mecha‐
nism by improving vascular and connective tissue status of urethral tissues after VD [43]. 
In another study, human mesenchymal stromal cells were isolated, expanded and char‐
acterized. These cells were injected trans‐urethrally in immune‐suppressed Göttingen 
Minipigs. The study found this cellular sphincter therapy in Göttingen Minipigs as very 
safe and effective against SUI [44]. Some animal studies employed dogs with induced SUI 
and injected SCs therapy to test safety and efficacy for SUI treatment and found similar 
results [45].
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4.2. Conservative treatment of UUI
Clinical observations as well as results from recent studies on murine showed that 
 iatrogenic bladder outlet obstruction leads to a rise in detrusor pressure, mimicking leak 
in humans secondary to detrusor overactivity (DO) in cases of UUI. Murines were induced 
DO and then treated by the use of botulinum toxin A (BoNT‐A). The therapeutic effects 
of intramural injections of botulinum toxin A (BoNT‐A) into the bladder wall resulted in 
suppression of detrusor overactivity in murine as seen in human bladder, and the refrac‐
tory cases of UUI secondary to DO have shown same results with botulinum toxin A 
(BoNT‐A) [46].
4.3. Conservative treatment of FI
Modifying irregular bowel habits is often the first step to manage FI. Pelvic floor exer‐
cises with and without biofeedback therapy, reusable bodyworn products and antidiar‐
rheal treatment all play some role in treatment of FI. Sacral nerve stimulation (SNS) and 
stem cell therapy for improving contractile function of anal sphincter have been studied 
on animal models.
4.3.1. Sacral nerve stimulation (SNS) therapy
Fecal incontinence is multifactorial in origin. Most of the human studies have focused on anal 
sphincter functions and its restoration for treatment of FI. There have been numerous animal 
studies which investigated direct effects of SNS on the muscles of continence. In one study, 
ten dogs received electrical stimulation of the sacral plexus. Histochemical analysis of the 
striated external anal sphincter following chronic electrical stimulation demonstrated hyper‐
trophy of stimulated muscle fibers. However, these changes reverted to pre‐stimulation level 
3 months after the stimulation. Anal tone and reflexes were measured before and during acute 
stimulation and demonstrated that SNS did not have any significant effect on internal anal 
sphincter or external anal sphincter force, the recto‐anal inhibitory or recto‐anal excitatory 
reflexes, internal anal sphincter slow wave frequency or wave amplitude [47]. The mechanism 
of action of SNS with the use of surgically implanted interstim is not very clear; however, it 
was found to be very effective in patients with FI [48].
4.3.2. Stem cell therapy
Stem cell injection at the site of injury can enhance contractile function of the anal sphincter 
without surgical repair. Human umbilical cord matrix (hUCM) cells have been described 
as having the characteristics of myofibroblasts, which play a role in healing by producing a 
wide range of cytokines, growth factors, chemokines and inflammatory mediators. Rabbit 
bone marrow (rBM) cells are known to secrete many growth factors which contribute to cell 
propagation and differentiation. Harvested hUCM and rBM stem cells from rabbit femurs 
and tibias were injected in surgically incised external anal sphincter of the white New 
Zealand rabbits. Electromyography showed significant improvement in sphincter function 2 
weeks after local injection of rBM stem cells, and histopathologic evaluation showed normal 
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or muscle‐dominant sphincter structure in all animals receiving rBM and fibrous‐dominant 
sphincter structure in most animals receiving hUCM cells [8].
5. The role of animal studies in surgical management of DI
5.1. Surgical treatment of SUI
There are a variety of surgical treatment options for SUI. The two most effective procedures 
are Burch colposuspension and miduretheral slings (MUS), which are available in different 
synthetic material. Each material has been tested for its efficacy and safety. There are many 
animal studies regarding the use of mesh before its use in human.
5.1.1. Efficacy of slings tested by LPP
Surgical management including the suburethral sling is one of the most common treatment 
options for SUI, with an overall objective cure rate of 82% [49]. Suburethral sling therapy 
provides stability to the supporting layer under the urethra and helps in leak of urine against 
the rise in abdominal pressure. The urethra remains compressed against the suburethral 
sling, and continence is maintained. While a sling procedure offers the highest success rate, 
it also results in the highest morbidity and complication rate among all anti‐incontinence 
procedures. In the last several years, a number of modifications to the sling procedure have 
been proposed to improve its safety and efficacy while decreasing morbidity. SUI in rats was 
induced by pudendal nerve transaction (PNT), they were treated by polypropylene subure‐
thral sling and the efficacy of sling was assessed by an increase in LPP [50].
5.1.2. Tissue reaction of different sling materials
Tension‐free vaginal tape (TVT) with polypropylene was first introduced by Ulmsten for 
surgical treatment of SUI and has shown good success rate [51]. The tensile properties of 
polypropylene used in TVT were studied in rats and found to be significantly greater than 
cadaveric fascia lata [52]. There have been many other sling procedures using same mate‐
rial with different surgical approaches. Another study on white rabbits has evaluated tissue 
reactions to five sling materials used in five different procedures like tension‐free vaginal 
tape (TVT), intravaginal slingplasty (IVS) for SUI surgery and polypropylene mesh for hernia 
repair. The other two procedures to cure SUI included suprapubic approach using subure‐
thral polypropylene tape and cadaveric fascia lata. Rabbit abdominal skin was incised, and 
a patch of all five sling material was attached with absorbable suture. Study compared the 
mesh‐to‐tissue attachment strength of four sling mesh materials on days 2, 7, 15 and 30 after 
implantation by electron microscopic studies. All five synthetic sling materials produced 
similar tissue reactions beginning soon after implantation. Cadaveric fascia lata persisted in 
tissue with remarkable perifascial fibrosis at day 30. When comparing the four polypropylene 
mesh materials, the attachment capacity of TVT was superior and that of IVS was the least of 
the four. TVT was statistically better than IVS at all data points. Suprapublic approach with 
polypropylene and hernia mesh provided results similar to those of TVT [53].
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5.2. Surgical treatment of FI
Obstetric anal sphincter trauma is the most common cause of fecal incontinence with a severe 
impact on quality of life. Anal sphincter rupture is reported in about 2.5% of vaginal deliveries 
in centers that practice mediolateral episiotomy and about 11% in centers that practice mid‐
line episiotomy [54]. The effect of anal sphincter laceration (with repair) at the time of parturi‐
tion after term pregnancy on physiologic function of the external anal sphincter was studied 
on eighty rats [55]. Overall, anal sphincter laceration at time of delivery results in signifi‐
cantly impaired anal function. Rat anal sphincter neurophysiologic functions were assessed. 
Recovery of sphincter function was evident as early as three months and maintained at six 
months after injury. The diagnosis and repair of sphincter tear is very important. Unrepaired 
or badly repaired sphincter can lead to FI. Several simulator models have been developed to 
provide surgical training to consultants, midwives and trainees. The early diagnosis of anal 
sphincter injury is very important for effective surgical outcome. The pig model was intro‐
duced due to its similarity to both internal and external anal sphincters [56]. The model used 
cadaveric pig perineum with a clear demarcation between internal and external anal sphinc‐
ters simulating human sphincters. Another study showed effective teaching of repair of peri‐
neal tears using goat perineum model (Figure 2), which mimics human female anatomy [57]. 
Both anal sphincter latex/plastic and cadaveric animal sphincter models have been effectively 
used for hands on training in different workshops.
5.2.1. Artificial anal sphincter
The artificial anal sphincter is used in cases where other treatment modalities fail. It includes 
an inflatable expander that compresses and flattens the bowel against a pillow. Before its 
Figure 2. Multiperous goat. Cut edge of external anal sphincter (E) held by Allis forceps, (I) internal anal sphincter 
between anal canal (A) and (E) external anal sphincter.
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experiment on humans, it was tried in 16 animals. In experimental animals, anal sphincters 
were destroyed and artificial sphincter device was implanted. The animals were observed for 
twenty weeks. The study concluded the safety of implanted sphincter against anal ischemia. 
Moreover, animals were continent during 85% of activation times [58].
6. Animal genetic models developed for incontinence/SUI studies
During last decade, investigators have developed and tested animal models of SUI in the 
female rat, seeking to mimic the symptoms of SUI in female patients. Bilateral pudendal nerve 
crush injury or transection or sciatic nerve transection has been used to cause SUI in rats. The 
VD model was used by Lin et al. [28] to simulate the damage that occurs in the pelvic floor 
during vaginal delivery of children. They demonstrated the feasibility of creating a mouse 
model of acute SUI by VD. Distention volumes of 0.1–0.3 ml in 20 g female mice of strain 
C57BL/6 resulted in significant reductions of LP, possibly due to partial urethral denervation. 
This novel model of SUI in mice could be used in future mechanistic studies of female SUI 
treatment. The childbirth induced vaginal distension, and SUI can be correlated but women 
recover out of these transient changes with only few remaining symptomatic for SUI. There 
is a need to develop specific mouse genetic models for incontinence/SUI induced by VD. 
Further studies can be performed to know the spontaneous cure of incontinence.
7. Conclusion
The use of animal models has helped in understanding the pathogenesis and etiology of 
both urinary and fecal incontinence. Due to ethical issues related to human cadaveric stud‐
ies, animal models are good substitute for research related to surgical innovations for treat‐
ment of double incontinence. Animal models like sheep, goat and pig have been validated 
for surgical training for perineal tears. The latest use of animal model is related to stud‐
ies on mouse for simulated birth trauma‐induced SUI and stem cell treatment for double 
incontinence.




SUI Stress urinary incontinence
UUI Urgency urinary incontinence
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